Joe Terranova incyte INCY-Q DON'T BUY Jun 16, 2025

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

Joe Terranova

Owned

Unlock Rating

$71.220

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

Most Recent Experts

Brendan Caldwell

Caldwell Securities

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Peter Hodson

5i Research Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Joe Terranova incyte INCY-Q DON'T BUY Jun 16, 2025

You might be interested:

incyte(INCY-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals